5:32 PM
 | 
Feb 25, 2013
 |  BC Extra  |  Company News

Eisai sets Belviq price

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) disclosed in an SEC filing that partner Eisai Co. Ltd. (Tokyo:4523; Osaka:4523) set a wholesale acquisition cost (WAC) of $199.50...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >